EDIE WILLIS: Open Payments
NPI 1356877328 · LOS ANGELES, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,110 in 47 payments from 17 companies in 2025. Trend: 2023 $1,919 · 2024 $13 · 2025 $1,110
Food & beverage: $1,089Education: $21
| Company | Payments | Amount |
|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | 7 | $179 |
| Mallinckrodt Hospital Products Inc. | 7 | $166 |
| Averitas Pharma Inc. | 5 | $157 |
| Otsuka America Pharmaceutical, Inc. | 5 | $145 |
| Travere Therapeutics, Inc. | 4 | $62 |
| ANI Pharmaceuticals, Inc. | 2 | $59 |
| Ardelyx, Inc. | 2 | $58 |
| AstraZeneca Pharmaceuticals LP | 3 | $45 |
| Amgen Inc. | 2 | $40 |
| GlaxoSmithKline, LLC. | 2 | $40 |
Products named: Kerendia, QUTENZA, JYNARQUE, ACTHAR, TERLIVAZ, PURIFIED CORTROPHIN GEL, IBSRELA, FARXIGA.
Industry payments across CA — which companies pay providers there.
